Today Tabula Rasa HealthCare, Inc. (TRHC) Stock Reaches 52-Week High

May 25, 2018 - By Maria Brooks

The stock of Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC) hit a new 52-week high and has $56.25 target or 8.00 % above today’s $52.08 share price. The 5 months bullish chart indicates low risk for the $1.04 billion company. The 1-year high was reported on May, 25 by Barchart.com. If the $56.25 price target is reached, the company will be worth $83.36M more.
The 52-week high event is an important milestone for every stock because it shows very positive momentum and is time when buyers come in. During such notable technical setup, fundamental investors usually stay away and are careful shorting or selling the stock.

The stock decreased 1.74% or $0.92 during the last trading session, reaching $52.08. About 110,009 shares traded. Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC) has risen 198.94% since May 25, 2017 and is uptrending. It has outperformed by 187.39% the S&P500.

Analysts await Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC) to report earnings on August, 6. They expect $0.08 EPS, up 188.89 % or $0.17 from last year’s $-0.09 per share. TRHC’s profit will be $1.60 million for 162.75 P/E if the $0.08 EPS becomes a reality.

More notable recent Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC) news were published by: Globenewswire.com which released: “Tabula Rasa HealthCare to Participate in Upcoming Investor Conferences” on May 24, 2018, also Globenewswire.com with their article: “Tabula Rasa HealthCare Releases Research Results Re: Pharmacist-Led Pharmacogenomics (PGx) Services for PACE” published on May 09, 2018, Globenewswire.com published: “Tabula Rasa HealthCare Subsidiary CareKinesis Signs Agreement with SpiriTrust Lutheran LIFE” on April 30, 2018. More interesting news about Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC) were released by: Globenewswire.com and their article: “Tabula Rasa HealthCare Announces First Quarter 2018 Operating Results” published on May 08, 2018 as well as Globenewswire.com‘s news article titled: “Peak PACE Solutions to Join Capstone Performance Systems” with publication date: May 03, 2018.

Tabula Rasa HealthCare, Inc. provides patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to enhance patient outcomes, reduce hospitalizations, lower healthcare costs, and manage risk. The company has market cap of $1.04 billion. The Company’s cloud software applications include EireneRx, which is used by at-risk healthcare organizations to access its patients' medication-related information; MedWise Advisor that allows for components of EireneRx to be used independently and by a broader healthcare audience; and NiaRx, an educational software platform used in the pharmacy educational community. It currently has negative earnings. The firm offers its technology-enabled services and products for medication risk management and risk adjustment.

Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: